Ovoca Bio | OVG - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 4.83M 359.32M 2025-12
Alaunos Therapeutics USD 1.07M 215K 2023-06
ALKERMES USD 12.28M 7.63M 2025-12
Avita Medical AUD 1.25M 100K 2025-06
Dianthus Therapeutics USD 4.44M 263K 2024-09
Ionis Pharmaceuticals USD 18M 0 2025-12
IQVIA Holdings USD 193M 4M 2025-12
Moderna USD 12.14B 12.13B 2025-09
Organon & Co USD 128M 3M 2025-09
Ovoca Bio EUR 7K 6K 2022-06
Revvity USD 23.51M 742K 2025-12
Tectonic Therapeutic USD 12K 276.99M 2025-12
Viatris USD 119.6M 0 2025-12
Xeris Pharmaceuticals USD 7.15M 115K 2025-12